Deal of The Day! Hurry Up, Grab the Special Discount - Save 25% - Ends In 00:00:00 Coupon code: SAVE25
Welcome to Pass4Success

- Free Preparation Discussions

CIPS Exam L4M6 Topic 3 Question 64 Discussion

Actual exam question for CIPS's L4M6 exam
Question #: 64
Topic #: 3
[All L4M6 Questions]

[Partnership and collaboration models]

Grey Stone Memorial Hospital is a private medical facility which has an idea for a vaccine to a deadly disease, but does not have the capacity to make the vaccine itself. It is considering partnering with a well-known pharmaceutical company in order to bring the vaccine to market. What is the biggest risk to Grey Stone?

Show Suggested Answer Hide Answer
Suggested Answer: A

Contribute your Thoughts:

Cherelle
1 months ago
I agree, the IP rights are crucial. They better get a good lawyer to draw up that contract!
upvoted 0 times
Lang
18 days ago
A) Intellectual Property Rights
upvoted 0 times
...
...
Isadora
1 months ago
Uninformed stakeholders? That's a good one. How about 'Disgruntled shareholders who can't get their hands on the vaccine first'?
upvoted 0 times
...
Gilberto
2 months ago
Low quality product is a risk too. They need to ensure the pharma company can manufacture the vaccine to their standards.
upvoted 0 times
Francene
10 days ago
B) Increased Costs
upvoted 0 times
...
Rebecka
15 days ago
A) Intellectual Property Rights
upvoted 0 times
...
...
Alverta
2 months ago
But what about B) Increased Costs? Partnering with a big company could lead to unexpected expenses for Grey Stone.
upvoted 0 times
...
Quiana
2 months ago
I agree with Eric. If they partner with a pharmaceutical company, they might lose control over their vaccine's intellectual property.
upvoted 0 times
...
Eric
2 months ago
I think the biggest risk to Grey Stone is A) Intellectual Property Rights.
upvoted 0 times
...
Arlette
2 months ago
Increased Costs could also be a major concern. The partnership might end up costing more than Grey Stone expected.
upvoted 0 times
...
Willis
2 months ago
I think the biggest risk to Grey Stone is Intellectual Property Rights. They need to make sure their vaccine formula is protected before partnering with the pharma company.
upvoted 0 times
Veronika
1 months ago
C) Low quality product
upvoted 0 times
...
Elke
1 months ago
B) Increased Costs
upvoted 0 times
...
Freeman
2 months ago
A) Intellectual Property Rights
upvoted 0 times
...
...

Save Cancel